Allergy, Asthma, and Atopic Eczema in Finland

Not yet recruiting

• Conditions: Rhinitis, Allergic; Atopic Dermatitis; Asthma; Asthma in Children; Allergy; Allergen Immunotherapy

• Registration Number: NCT06330974
• Lead Sponsor: Tampere University

Brief Summary

The summary is available at --\> https://www.finnatopy.fi/summary

Detailed Description

Aims and objectives ---\> https://www.finnatopy.fi/aims-and-objectives Methods ---\> https://www.finnatopy.fi/methods

Study Timeline

• Status Verified: 2024-03
• Study First Submitted: 2024-03-12
• Study First Submitted QC: 2024-03-19
• Last Update Submitted: 2024-03-19
• Study First Posted: 2024-03-26
• Last Update Posted: 2024-03-26
• Study Start: 2024-10
• Primary Completion: 2032-12
• Study Completion: 2034-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 2000000

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland	7 years	Morbidity, sick leaves, medication use, costs and expences
Use and effectiveness of allergen immunotherapy in real world setting	7 years	Real world evidence data using specific cohorts
Epidemiology of atopic diseases and allergic sensitization profiles in Finland	7 years	Incidence and prevalence of asthma, specific IgE sensitization, atopic dermatitis, allergic rhinitis
Evaluate and improve the current use of diagnostic tests for atopic diseases	7 years	Diagnostic practices, tests for allergic sensitization, lung function tests, and other laboratory measures.
Direct and indirect costs related to atopic diseases and comorbidities	7 years	All costs, including sick leaves, absenteeism, laboratory costs, other diagnisteic tests, etc.

Trial Locations

Locations (1)

Tampere University; 🇫🇮 Tampere, Finland